Supplier
Supplier
Pfizer Pharma GmbH
Location unknown
This contract involves establishing active ingredient-based discount agreements in accordance with § 130a Abs. 8 SGB V for specific pharmaceuticals. The agreements will be in effect for a maximum period of 24 months, starting no earlier than April 1, 2026, and ending uniformly on March 31, 2028. Sup
The contract involves the delivery of a range of pharmaceuticals. The total value of the contract is approximately €538,742.40. This opportunity is aimed at suppliers in the health sector, specifically for the provision of diverse medicinal products. The contract is awarded by the Federal Office for